ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.01
-1.60%
US Tech 100
18,192.80
-0.35%
S&P 500
5,266.95
-0.74%
US Dollar vs CAD
1.37126
-0.05%
Bitcoin
67,581.31
0.00%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/30/20244:25AMPR Newswire (Canada)CIBC Announces Second Quarter 2024 ResultsTSX:CMCanadian Imperial Bank of Commerce
05/30/20244:25AMPR Newswire (Canada)CIBC Announces Second Quarter 2024 ResultsNYSE:CMCanadian Imperial Bank of Commerce
05/30/20244:24AMPR Newswire (US)Trip.com Group Outlines Future Growth Strategies at Envision 2024 Global Partner Conference
05/30/20244:24AMPR Newswire (Canada)Trip.com Group Outlines Future Growth Strategies at Envision 2024 Global Partner Conference
05/30/20244:15AMPR Newswire (US)American Council of Learned Societies Names 21 New ACLS Leading Edge Fellows
05/30/20244:09AMPR Newswire (US)Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone
05/30/20244:00AMPR Newswire (US)InxMed Reports Positive Phase Ib/II Results for Ifebemtinib in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
05/30/20244:00AMPR Newswire (Canada)Canadian medical organizations call on federal government to exempt physicians from increase to capital gains inclusion rate
05/30/20244:00AMPR Newswire (US)Patoranking Foundation and ALX Africa Unveil a $500,000 Scholarship Initiative for Tech-Savvy African Youth
05/30/20244:00AMPR Newswire (Canada)Les organisations médicales canadiennes demandent au gouvernement fédéral de dispenser les médecins de l'augmentation du taux d'inclusion des gains en capital
05/30/20244:00AMPR Newswire (US)Patoranking Foundation and ALX Africa Unveil a $500,000 Scholarship Initiative for Tech-Savvy African Youth
05/30/20244:00AMPR Newswire (US)Omnicom Appoints Mazen Abd Rabbo as SVP of Newly Formed Omnicom Group QatarNYSE:OMCOmnicom Group Inc
05/30/20243:49AMPR Newswire (US)Zhihu Inc. to Hold Annual General Meeting on June 26, 2024NYSE:ZHZhihu Inc
05/30/20243:37AMPR Newswire (US)LG Innotek recognized as one of South Korea's top brands
05/30/20243:35AMPR Newswire (US)First National Bank & Trust Announces Rebranding to Patrons Bank in June 2024
05/30/20243:31AMPR Newswire (US)XTrend Speed Unveils New Cutting-Edge Features to Empower Traders
05/30/20243:30AMPR Newswire (US)Astrid & Miyu Selects Movable Ink as Personalisation Engine for Email Marketing
05/30/20243:23AMPR Newswire (US)Laura and Jason Vahle Expand Spring Green Franchise to Three Territories in St. Charles, MO
05/30/20243:22AMPR Newswire (US)Yiren Digital's AI-powered Intelligent Customer Service Wins 'Outstanding Solution' Award at Data Modeling Algorithm CompetitionNYSE:YRDYiren Digital Ltd
05/30/20243:05AMPR Newswire (US)Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata
05/30/20243:02AMPR Newswire (US)Masan High-Tech Materials Group and Mitsubishi Materials Corporation Group Signed Definitive Agreements
05/30/20243:00AMPR Newswire (US)Pini goes to Africa
05/30/20243:00AMPR Newswire (US)NTC gives long term consistency to its ophtha portfolio with another MDR CE Certificate approval
05/30/20243:00AMPR Newswire (US)Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System
05/30/20243:00AMPR Newswire (US)Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System
05/30/20242:30AMPR Newswire (US)Vesper Bio announces completion of single ascending dose stage in trial of its lead candidate VES001, a potentially disease-modifying treatment for fronto-temporal dementia
05/30/20242:30AMPR Newswire (US)Vesper Bio announces completion of single ascending dose stage in trial of its lead candidate VES001, a potentially disease-modifying treatment for fronto-temporal dementia
05/30/20242:26AMPR Newswire (US)XCMG Stays Firm in 3rd Position on AccessM20 Manufacturer List for Its Stunning 41.9% Yearly Increase in 2023
05/30/20242:19AMPR Newswire (US)United Kingdom Atomic Energy Authority (UKAEA) signs MoU with Nordic's first fusion energy company, Novatron Fusion Group
05/30/20242:18AMPR Newswire (US)Masan High-Tech Materials Group and Mitsubishi Materials Corporation Group Signed Definitive Agreements

Your Recent History

BIT
I06614
Intesa Sanpaolo
LSE
42IE
Consort Tam.41
COIN
PNDRGBP
BIT
UV4L4M
UniCredit Bank
AMEX
AGZ
iShares Agency
USOTC
GPOVY
Grupo Carso Sa de CV (PK)
DGFX
CHERUSDT
Cherry Token
LATK
PPAYUSDT
Plasma
USOTC
GSRFF
Golden Shield Resources (QB)
TG
TUI1
Tui
USOTC
ATSKF
Allied Telesis Holdings KK (PK)
USOTC
ISRPF
Ishares Plc Resources NL (PK)
USOTC
USSJY
USS (PK)
LSE
61SP
Sg Issuer23
TG
ZX7
Gladiator Metals
TSXV
AST
Astron Connect
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved